SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 540.77 |
| Enterprise Value ($M) | 416.49 |
| Book Value ($M) | 777.79 |
| Book Value / Share | 4.59 |
| Price / Book | 0.70 |
| NCAV ($M) | 715.70 |
| NCAV / Share | 4.22 |
| Price / NCAV | 0.76 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.41 |
| Return on Assets (ROA) | -0.40 |
| Return on Equity (ROE) | -0.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 15.95 |
| Current Ratio | 15.95 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 809.20 |
| Assets | 871.30 |
| Liabilities | 93.50 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 10.01 |
| Operating Income | -385.67 |
| Net Income | -337.71 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -249.11 |
| Cash from Investing | -41.08 |
| Cash from Financing | 270.15 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 6.10 | -29.75 | |
| 13G | Point72 Asset Management, L.P. | 5.70 | ||
| 13G/A | Price T Rowe Associates Inc /md/ | 3.30 | -38.53 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 385,155 | 1,479,286 | 26.04 | |
| 298,768 | 1,330,201 | 22.46 | |
| 704,583 | 2,356,493 | 29.90 | |
| 449,188 | 1,715,628 | 26.18 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RANI – Rani Therapeutics Holdings, Inc. | RAPT – RAPT Therapeutics, Inc. |
| RCKT – Rocket Pharmaceuticals, Inc. | RNA – Avidity Biosciences, Inc. |
| RNAC – Cartesian Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io